| Full Name | Jing Guo |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 5645 Main St, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861836967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 286544 (New York) | Primary |
| 207R00000X | Internal Medicine | 055467 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian/queens | Flushing, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Queens Medicine And Surgery, P.c. | 4082883673 | 371 |
News Archive
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia.
Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.
Gestational diabetes can put babies at a lifelong risk for cardiovascular disease, and scientists want to better understand how.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
› Verified 3 days ago
| Entity Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia.
Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.
Gestational diabetes can put babies at a lifelong risk for cardiovascular disease, and scientists want to better understand how.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jing Guo, MD 5645 Main St, Flushing, NY 11355-5045 Ph: (916) 712-9828 | Jing Guo, MD 5645 Main St, Flushing, NY 11355-5045 Ph: (916) 712-9828 |
News Archive
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia.
Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.
Gestational diabetes can put babies at a lifelong risk for cardiovascular disease, and scientists want to better understand how.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
› Verified 3 days ago
Dr. Saquib Rahim, MD, MBA Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1000 | |
Mr. Shamit P Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Boulevard, New York Flushing Hospital & Medical Center, Flushing, NY 11355 Phone: 718-670-5000 Fax: 610-617-6280 | |
Yongzeng Ding, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13630 Maple Ave Ste 2f, Flushing, NY 11355 Phone: 516-806-2288 Fax: 718-888-9600 | |
Dr. Antonin Jiri Reznicek, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 14015 Sanford Ave, Flushing, NY 11355 Phone: 718-826-4000 Fax: 718-826-4075 | |
Dr. Choudhury Mohammed Sajedul Hasan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 14056 Quince Ave, Flushing, NY 11355 Phone: 347-837-8117 | |
Binh Huynh, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Ghulam Murtaza Shah, MBBS Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 631-880-9789 |